Business Description
Artiva Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US04317A1079
Description
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.8 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 4.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -17.1 | |||||
| 3-Year EPS without NRI Growth Rate | -17.7 | |||||
| 3-Year FCF Growth Rate | -54.2 | |||||
| 3-Year Book Growth Rate | -44.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.19 | |||||
| 9-Day RSI | 48.62 | |||||
| 14-Day RSI | 47.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.33 | |||||
| Quick Ratio | 11.33 | |||||
| Cash Ratio | 11.03 | |||||
| Days Sales Outstanding | 104.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.5 | |||||
| Shareholder Yield % | 1.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2344.75 | |||||
| Net Margin % | -2189.39 | |||||
| FCF Margin % | -2009.65 | |||||
| ROA % | -45.85 | |||||
| ROIC % | -147.38 | |||||
| ROC (Joel Greenblatt) % | -264.42 | |||||
| ROCE % | -54.2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 85.63 | |||||
| PB Ratio | 1.32 | |||||
| Price-to-Tangible-Book | 1.32 | |||||
| EV-to-EBIT | -2.02 | |||||
| EV-to-EBITDA | -2.1 | |||||
| EV-to-Revenue | 47.25 | |||||
| EV-to-FCF | -2.35 | |||||
| Price-to-Net-Current-Asset-Value | 2.11 | |||||
| Price-to-Net-Cash | 2.18 | |||||
| Earnings Yield (Greenblatt) % | -49.5 | |||||
| FCF Yield % | -19.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARTV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Artiva Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.601 | ||
| EPS (TTM) ($) | -3.505 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 47.5 | ||
| 14-Day ATR ($) | 1.101139 | ||
| 20-Day SMA ($) | 11.5015 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 9.68 - 17.31 | ||
| Shares Outstanding (Mil) | 24.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Artiva Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Artiva Biotherapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Artiva Biotherapeutics Inc Frequently Asked Questions
What is Artiva Biotherapeutics Inc(ARTV)'s stock price today?
The current price of ARTV is $10.96. The 52 week high of ARTV is $17.31 and 52 week low is $9.68.
When is next earnings date of Artiva Biotherapeutics Inc(ARTV)?
The next earnings date of Artiva Biotherapeutics Inc(ARTV) is 2025-02-28 Est..
Does Artiva Biotherapeutics Inc(ARTV) pay dividends? If so, how much?
Artiva Biotherapeutics Inc(ARTV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers